Home NDC 42291-788-30 Tadalafil
Product NDC 42291-788
Requested package NDC 42291-788-30
11-digit product format 422910788
Labeler code 42291
Product ID 42291-788_c7026e67-7463-7fdc-e053-2a95a90a00d4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tadalafil
Dosage form TABLET, FILM COATED
Route ORAL
Labeler AvKARE
Application ANDA090141
Marketing category ANDA
Marketing start 2018-10-09
Marketing end 0000-00-00
Substance TADALAFIL
Active strength 10 mg/1
Pharmacologic classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090141-001 TADALAFIL TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 A090141-002 TADALAFIL TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 A090141-003 TADALAFIL TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 A090141-004 TADALAFIL TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
Observed Orange Book exclusivity history# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42291-788-30 42291078830 30 TABLET, FILM COATED in 1 BOTTLE (42291-788-30) 2018-10-09 0000-00-00 No No Current